13.jpg

Abstract - BEYOND PSA - PROSTATE CANCER BIOMARKERS IN PROSTATE CANCER DIAGNOSIS 

Lincoln Tan Guan Lim, MBBS (Singapore), MMed (Surgery), FRCS (Urol)(RCPSG)

National University Hospital Singapore

PSA is a deeply flawed tumour marker that is responsible for much misery. New biomarkers with improved performance that are commercially available will be reviewed.

back to Clinical Pathology Speakers

 

Philippine Society of Pathologists, Inc. — Project F Sharp

All Rights Reserved 2018